Trial Search Results
Stress, Diurnal Cortisol, and Breast Cancer Survival
The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.
Stanford is currently not accepting patients for this trial.
Collaborator: National Institute on Aging (NIA)
- Drug: Sandostatin
1. Diagnosis of recurrent or metastatic breast cancer.
2. Karnofsky of 70% or greater.
3. Proficient enough in English to be able to take questionnaires and participate in the
4. Living within the Greater Bay Area.
5. Age 35 or older .
1. Positive supraclavicular lymph nodes as the only metastatic lesion at the time of
2. Active cancers within the past 10 years other than breast cancer, basal cell or
squamous cell carcinomas of the skin, or in situ cancer of the cervix.
3. Any other serious medical condition that will effect short term survival
4. History of major psychiatric illness for which patient was hospitalized or medicated,
with the exception of depression or anxiety
5. A diagnosis of diabetes.
Ages Eligible for Study
35 Years - N/A
Genders Eligible for Study